Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 580796, 6 pages
http://dx.doi.org/10.1155/2013/580796
Clinical Study

Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients

1Centro A.M. e A. Migliavacca, First Division of Gastroenterology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano, Università degli Studi di Milano, Via F. Sforza 35, 20122 Milano, Italy
2Division of Hepatology, Ospedale San Giuseppe IRCCS MultiMedica, Università degli Studi di Milano, 20122 Milano, Italy
3Division of Internal Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, 20122 Milano, Italy
4Istituto Nazionale Genetica Molecolare Milano (INGM), 20122 Milano, Italy

Received 26 April 2013; Accepted 19 June 2013

Academic Editor: Kusum Kharbanda

Copyright © 2013 Alessio Aghemo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Alessio Aghemo, Elisabetta Degasperi, Maria Grazia Rumi, et al., “Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients,” BioMed Research International, vol. 2013, Article ID 580796, 6 pages, 2013. https://doi.org/10.1155/2013/580796.